This site is intended for healthcare professionals
Optimising anti-TNF treatment using biosimilars Learning Zone

Expert Opinion

Last updated:29th Jun 2021
Published:29th Oct 2020

Explore independently-led content from leading experts on the use of αTNF biosimilars to treat three conditions and discover:

  • The role of αTNF biosimilars in rheumatoid arthritis and the common misconceptions of biosimilars in rheumatology
  • The considerable burden of hidradenitis suppurativa and the future of biosimilars in dermatology
  • Strategies for treating inflammatory bowel disease with αTNF biosimilars

Do you know the latest insights on the use of αTNF biosimilars in rheumatoid arthritis, hidradenitis suppurativa, and inflammatory bowel disease? In these illuminating expert-led interviews, Professor Thomas Dörner, Dr Joana Cabete, and Dr Nick Kennedy explore αTNF treatment initiation, optimisation, and maintenance, as well as αTNF treatment during COVID-19.

Also find out about the future of biosimilars in dermatology and the most common misconceptions of biosimilars in rheumatology with Professor Tiago Torres and Professor Joao Goncalves.

Know the latest insights on the use of αTNF biosimilars in rheumatoid arthritis? Watch these videos on treatment initation and optimisation.

Biological disease-modifying antirheumatic drugs (DMARDs), such as anti tumour necrosis factor (αTNF), are an important component of treatment for patients with rheumatic diseases1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Want to hear the latest on hidradenitis suppurativa? Watch the videos below to learn about the unmet needs of this disease, the use of αTNF treatment and the impact of COVID-19.

Hidradenitis suppurativa (HS) is a prevalent and devastating inflammatory skin disease characterised by painful recurrent abscesses, foul-smelling purulent drainage, sinus tract and fistula formation, and disfiguring scarring involving intertriginous body sites1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Watch these videos to find out the latest advice on treating inflammatory bowel disease covering the initiation, optimisation and maintenance of treatment and impact of COVID-19.

Inflammatory bowel diseases can result in debilitating physical and psychosocial symptoms for patients and affect society through loss of schooling, absenteeism, and health-care costs1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: